CD8A and neoplasm: Similarly, in an HPV tumor‐bearing mouse model developed by Peng et al., a single prevaccination dose of CTX achieved comparable immune activation to prolonged daily low‐dose administration, while effectively avoiding depletion of CD8+ T cells [367].